Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Age Related Macular Degeneration (AMD) Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Wet AMD
1.2.3 Dry AMD
1.3 Market by Application
1.3.1 Global Age Related Macular Degeneration (AMD) Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Men
1.3.3 Woman
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Age Related Macular Degeneration (AMD) Market Perspective (2018-2033)
2.2 Age Related Macular Degeneration (AMD) Growth Trends by Region
2.2.1 Global Age Related Macular Degeneration (AMD) Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Age Related Macular Degeneration (AMD) Historic Market Size by Region (2018-2023)
2.2.3 Age Related Macular Degeneration (AMD) Forecasted Market Size by Region (2024-2033)
2.3 Age Related Macular Degeneration (AMD) Market Dynamics
2.3.1 Age Related Macular Degeneration (AMD) Industry Trends
2.3.2 Age Related Macular Degeneration (AMD) Market Drivers
2.3.3 Age Related Macular Degeneration (AMD) Market Challenges
2.3.4 Age Related Macular Degeneration (AMD) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Age Related Macular Degeneration (AMD) Players by Revenue
3.1.1 Global Top Age Related Macular Degeneration (AMD) Players by Revenue (2018-2023)
3.1.2 Global Age Related Macular Degeneration (AMD) Revenue Market Share by Players (2018-2023)
3.2 Global Age Related Macular Degeneration (AMD) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Age Related Macular Degeneration (AMD) Revenue
3.4 Global Age Related Macular Degeneration (AMD) Market Concentration Ratio
3.4.1 Global Age Related Macular Degeneration (AMD) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Age Related Macular Degeneration (AMD) Revenue in 2022
3.5 Age Related Macular Degeneration (AMD) Key Players Head office and Area Served
3.6 Key Players Age Related Macular Degeneration (AMD) Product Solution and Service
3.7 Date of Enter into Age Related Macular Degeneration (AMD) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Age Related Macular Degeneration (AMD) Breakdown Data by Type
4.1 Global Age Related Macular Degeneration (AMD) Historic Market Size by Type (2018-2023)
4.2 Global Age Related Macular Degeneration (AMD) Forecasted Market Size by Type (2024-2033)
5 Age Related Macular Degeneration (AMD) Breakdown Data by Application
5.1 Global Age Related Macular Degeneration (AMD) Historic Market Size by Application (2018-2023)
5.2 Global Age Related Macular Degeneration (AMD) Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Age Related Macular Degeneration (AMD) Market Size (2018-2033)
6.2 North America Age Related Macular Degeneration (AMD) Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Age Related Macular Degeneration (AMD) Market Size by Country (2018-2023)
6.4 North America Age Related Macular Degeneration (AMD) Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Age Related Macular Degeneration (AMD) Market Size (2018-2033)
7.2 Europe Age Related Macular Degeneration (AMD) Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Age Related Macular Degeneration (AMD) Market Size by Country (2018-2023)
7.4 Europe Age Related Macular Degeneration (AMD) Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Age Related Macular Degeneration (AMD) Market Size (2018-2033)
8.2 Asia-Pacific Age Related Macular Degeneration (AMD) Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Age Related Macular Degeneration (AMD) Market Size by Region (2018-2023)
8.4 Asia-Pacific Age Related Macular Degeneration (AMD) Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Age Related Macular Degeneration (AMD) Market Size (2018-2033)
9.2 Latin America Age Related Macular Degeneration (AMD) Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Age Related Macular Degeneration (AMD) Market Size by Country (2018-2023)
9.4 Latin America Age Related Macular Degeneration (AMD) Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Age Related Macular Degeneration (AMD) Market Size (2018-2033)
10.2 Middle East & Africa Age Related Macular Degeneration (AMD) Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Age Related Macular Degeneration (AMD) Market Size by Country (2018-2023)
10.4 Middle East & Africa Age Related Macular Degeneration (AMD) Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bayer
11.1.1 Bayer Company Detail
11.1.2 Bayer Business Overview
11.1.3 Bayer Age Related Macular Degeneration (AMD) Introduction
11.1.4 Bayer Revenue in Age Related Macular Degeneration (AMD) Business (2018-2023)
11.1.5 Bayer Recent Development
11.2 F. HoffmannLa Roche
11.2.1 F. HoffmannLa Roche Company Detail
11.2.2 F. HoffmannLa Roche Business Overview
11.2.3 F. HoffmannLa Roche Age Related Macular Degeneration (AMD) Introduction
11.2.4 F. HoffmannLa Roche Revenue in Age Related Macular Degeneration (AMD) Business (2018-2023)
11.2.5 F. HoffmannLa Roche Recent Development
11.3 Regeneron
11.3.1 Regeneron Company Detail
11.3.2 Regeneron Business Overview
11.3.3 Regeneron Age Related Macular Degeneration (AMD) Introduction
11.3.4 Regeneron Revenue in Age Related Macular Degeneration (AMD) Business (2018-2023)
11.3.5 Regeneron Recent Development
11.4 Novartis
11.4.1 Novartis Company Detail
11.4.2 Novartis Business Overview
11.4.3 Novartis Age Related Macular Degeneration (AMD) Introduction
11.4.4 Novartis Revenue in Age Related Macular Degeneration (AMD) Business (2018-2023)
11.4.5 Novartis Recent Development
11.5 Valeant
11.5.1 Valeant Company Detail
11.5.2 Valeant Business Overview
11.5.3 Valeant Age Related Macular Degeneration (AMD) Introduction
11.5.4 Valeant Revenue in Age Related Macular Degeneration (AMD) Business (2018-2023)
11.5.5 Valeant Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Detail
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Age Related Macular Degeneration (AMD) Introduction
11.6.4 Pfizer Revenue in Age Related Macular Degeneration (AMD) Business (2018-2023)
11.6.5 Pfizer Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Age Related Macular Degeneration (AMD) Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Wet AMD
Table 3. Key Players of Dry AMD
Table 4. Global Age Related Macular Degeneration (AMD) Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global Age Related Macular Degeneration (AMD) Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Age Related Macular Degeneration (AMD) Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Age Related Macular Degeneration (AMD) Market Share by Region (2018-2023)
Table 8. Global Age Related Macular Degeneration (AMD) Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Age Related Macular Degeneration (AMD) Market Share by Region (2024-2033)
Table 10. Age Related Macular Degeneration (AMD) Market Trends
Table 11. Age Related Macular Degeneration (AMD) Market Drivers
Table 12. Age Related Macular Degeneration (AMD) Market Challenges
Table 13. Age Related Macular Degeneration (AMD) Market Restraints
Table 14. Global Age Related Macular Degeneration (AMD) Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Age Related Macular Degeneration (AMD) Market Share by Players (2018-2023)
Table 16. Global Top Age Related Macular Degeneration (AMD) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Age Related Macular Degeneration (AMD) as of 2022)
Table 17. Ranking of Global Top Age Related Macular Degeneration (AMD) Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Age Related Macular Degeneration (AMD) Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Age Related Macular Degeneration (AMD) Product Solution and Service
Table 21. Date of Enter into Age Related Macular Degeneration (AMD) Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Age Related Macular Degeneration (AMD) Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Age Related Macular Degeneration (AMD) Revenue Market Share by Type (2018-2023)
Table 25. Global Age Related Macular Degeneration (AMD) Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Age Related Macular Degeneration (AMD) Revenue Market Share by Type (2024-2033)
Table 27. Global Age Related Macular Degeneration (AMD) Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Age Related Macular Degeneration (AMD) Revenue Market Share by Application (2018-2023)
Table 29. Global Age Related Macular Degeneration (AMD) Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Age Related Macular Degeneration (AMD) Revenue Market Share by Application (2024-2033)
Table 31. North America Age Related Macular Degeneration (AMD) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America Age Related Macular Degeneration (AMD) Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Age Related Macular Degeneration (AMD) Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Age Related Macular Degeneration (AMD) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe Age Related Macular Degeneration (AMD) Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Age Related Macular Degeneration (AMD) Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Age Related Macular Degeneration (AMD) Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific Age Related Macular Degeneration (AMD) Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Age Related Macular Degeneration (AMD) Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Age Related Macular Degeneration (AMD) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America Age Related Macular Degeneration (AMD) Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Age Related Macular Degeneration (AMD) Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Age Related Macular Degeneration (AMD) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa Age Related Macular Degeneration (AMD) Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Age Related Macular Degeneration (AMD) Market Size by Country (2024-2033) & (US$ Million)
Table 46. Bayer Company Detail
Table 47. Bayer Business Overview
Table 48. Bayer Age Related Macular Degeneration (AMD) Product
Table 49. Bayer Revenue in Age Related Macular Degeneration (AMD) Business (2018-2023) & (US$ Million)
Table 50. Bayer Recent Development
Table 51. F. HoffmannLa Roche Company Detail
Table 52. F. HoffmannLa Roche Business Overview
Table 53. F. HoffmannLa Roche Age Related Macular Degeneration (AMD) Product
Table 54. F. HoffmannLa Roche Revenue in Age Related Macular Degeneration (AMD) Business (2018-2023) & (US$ Million)
Table 55. F. HoffmannLa Roche Recent Development
Table 56. Regeneron Company Detail
Table 57. Regeneron Business Overview
Table 58. Regeneron Age Related Macular Degeneration (AMD) Product
Table 59. Regeneron Revenue in Age Related Macular Degeneration (AMD) Business (2018-2023) & (US$ Million)
Table 60. Regeneron Recent Development
Table 61. Novartis Company Detail
Table 62. Novartis Business Overview
Table 63. Novartis Age Related Macular Degeneration (AMD) Product
Table 64. Novartis Revenue in Age Related Macular Degeneration (AMD) Business (2018-2023) & (US$ Million)
Table 65. Novartis Recent Development
Table 66. Valeant Company Detail
Table 67. Valeant Business Overview
Table 68. Valeant Age Related Macular Degeneration (AMD) Product
Table 69. Valeant Revenue in Age Related Macular Degeneration (AMD) Business (2018-2023) & (US$ Million)
Table 70. Valeant Recent Development
Table 71. Pfizer Company Detail
Table 72. Pfizer Business Overview
Table 73. Pfizer Age Related Macular Degeneration (AMD) Product
Table 74. Pfizer Revenue in Age Related Macular Degeneration (AMD) Business (2018-2023) & (US$ Million)
Table 75. Pfizer Recent Development
Table 76. Research Programs/Design for This Report
Table 77. Key Data Information from Secondary Sources
Table 78. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Age Related Macular Degeneration (AMD) Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Age Related Macular Degeneration (AMD) Market Share by Type: 2022 VS 2033
Figure 3. Wet AMD Features
Figure 4. Dry AMD Features
Figure 5. Global Age Related Macular Degeneration (AMD) Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global Age Related Macular Degeneration (AMD) Market Share by Application: 2022 VS 2033
Figure 7. Men Case Studies
Figure 8. Woman Case Studies
Figure 9. Age Related Macular Degeneration (AMD) Report Years Considered
Figure 10. Global Age Related Macular Degeneration (AMD) Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 11. Global Age Related Macular Degeneration (AMD) Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 12. Global Age Related Macular Degeneration (AMD) Market Share by Region: 2022 VS 2033
Figure 13. Global Age Related Macular Degeneration (AMD) Market Share by Players in 2022
Figure 14. Global Top Age Related Macular Degeneration (AMD) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Age Related Macular Degeneration (AMD) as of 2022)
Figure 15. The Top 10 and 5 Players Market Share by Age Related Macular Degeneration (AMD) Revenue in 2022
Figure 16. North America Age Related Macular Degeneration (AMD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 17. North America Age Related Macular Degeneration (AMD) Market Share by Country (2018-2033)
Figure 18. United States Age Related Macular Degeneration (AMD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. Canada Age Related Macular Degeneration (AMD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. Europe Age Related Macular Degeneration (AMD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Europe Age Related Macular Degeneration (AMD) Market Share by Country (2018-2033)
Figure 22. Germany Age Related Macular Degeneration (AMD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. France Age Related Macular Degeneration (AMD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. U.K. Age Related Macular Degeneration (AMD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Italy Age Related Macular Degeneration (AMD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Russia Age Related Macular Degeneration (AMD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Nordic Countries Age Related Macular Degeneration (AMD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Asia-Pacific Age Related Macular Degeneration (AMD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Asia-Pacific Age Related Macular Degeneration (AMD) Market Share by Region (2018-2033)
Figure 30. China Age Related Macular Degeneration (AMD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Japan Age Related Macular Degeneration (AMD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. South Korea Age Related Macular Degeneration (AMD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Southeast Asia Age Related Macular Degeneration (AMD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. India Age Related Macular Degeneration (AMD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Australia Age Related Macular Degeneration (AMD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Latin America Age Related Macular Degeneration (AMD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Latin America Age Related Macular Degeneration (AMD) Market Share by Country (2018-2033)
Figure 38. Mexico Age Related Macular Degeneration (AMD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Brazil Age Related Macular Degeneration (AMD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Middle East & Africa Age Related Macular Degeneration (AMD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Middle East & Africa Age Related Macular Degeneration (AMD) Market Share by Country (2018-2033)
Figure 42. Turkey Age Related Macular Degeneration (AMD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Saudi Arabia Age Related Macular Degeneration (AMD) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Bayer Revenue Growth Rate in Age Related Macular Degeneration (AMD) Business (2018-2023)
Figure 45. F. HoffmannLa Roche Revenue Growth Rate in Age Related Macular Degeneration (AMD) Business (2018-2023)
Figure 46. Regeneron Revenue Growth Rate in Age Related Macular Degeneration (AMD) Business (2018-2023)
Figure 47. Novartis Revenue Growth Rate in Age Related Macular Degeneration (AMD) Business (2018-2023)
Figure 48. Valeant Revenue Growth Rate in Age Related Macular Degeneration (AMD) Business (2018-2023)
Figure 49. Pfizer Revenue Growth Rate in Age Related Macular Degeneration (AMD) Business (2018-2023)
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed